Analysen zu AstraZeneca PLC
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 23.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.07.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | AstraZeneca Overweight | Barclays Capital | |
| 18.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.06.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 28.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.05.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 25.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | AstraZeneca Outperform | Bernstein Research | |
| 23.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.12.23 | AstraZeneca Buy | UBS AG | |
| 12.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.12.23 | AstraZeneca Buy | UBS AG |
Aktuelle Aktienanalysen
| 04.04.25 | Walmart Outperform | RBC Capital Markets | |
| 04.04.25 | Alstom Buy | Jefferies & Company Inc. | |
| 04.04.25 | Schneider Electric Buy | Jefferies & Company Inc. | |
| 04.04.25 | Knorr-Bremse Buy | Jefferies & Company Inc. | |
| 04.04.25 | GEA Buy | Jefferies & Company Inc. | |
| 04.04.25 | Siemens Buy | Jefferies & Company Inc. | |
| 04.04.25 | Glencore Buy | Jefferies & Company Inc. | |
| 04.04.25 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 04.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 04.04.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 04.04.25 | Boeing Outperform | RBC Capital Markets | |
| 04.04.25 | SAFRAN Outperform | RBC Capital Markets | |
| 04.04.25 | Airbus Outperform | RBC Capital Markets | |
| 04.04.25 | Hapag-Lloyd Underweight | JP Morgan Chase & Co. | |
| 04.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 04.04.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | PUMA Sector Perform | RBC Capital Markets | |
| 03.04.25 | KION GROUP Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Nordex Buy | Jefferies & Company Inc. | |
| 03.04.25 | SAP Buy | Jefferies & Company Inc. | |
| 03.04.25 | adidas Halten | DZ BANK | |
| 03.04.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | Inditex Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Amazon Outperform | RBC Capital Markets | |
| 03.04.25 | Linde Buy | Jefferies & Company Inc. | |
| 03.04.25 | DocMorris Buy | Jefferies & Company Inc. | |
| 03.04.25 | Redcare Pharmacy Buy | Jefferies & Company Inc. | |
| 03.04.25 | Air Liquide Buy | Jefferies & Company Inc. | |
| 03.04.25 | Volkswagen Neutral | JP Morgan Chase & Co. | |
| 03.04.25 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | BMW Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Deutsche Euroshop Add | Baader Bank | |
| 03.04.25 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
| 03.04.25 | Sixt Buy | Deutsche Bank AG | |
| 03.04.25 | L'Oréal Sell | Deutsche Bank AG | |
| 03.04.25 | Roche Sell | Deutsche Bank AG | |
| 03.04.25 | Covestro Hold | Deutsche Bank AG | |
| 03.04.25 | NVIDIA Buy | UBS AG | |
| 03.04.25 | LVMH Moet Hennessy Louis Vuitton Neutral | UBS AG | |
| 03.04.25 | HELLA Hold | Deutsche Bank AG | |
| 03.04.25 | Kering Neutral | UBS AG | |
| 03.04.25 | Hermès Buy | UBS AG | |
| 03.04.25 | Siemens Hold | Deutsche Bank AG | |
| 03.04.25 | Richemont Buy | UBS AG | |
| 03.04.25 | HUGO BOSS Neutral | UBS AG | |
| 03.04.25 | EssilorLuxottica Neutral | UBS AG | |
| 03.04.25 | Ferrari Buy | UBS AG | |
| 03.04.25 | United Parcel Service Buy | UBS AG | |
| 03.04.25 | Lufthansa Underweight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.